lrcx-20211020
false000070754900007075492021-10-202021-10-20
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
 Current Report
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported): October 20, 2021
  LAM RESEARCH CORPORATION
(Exact name of registrant as specified in its charter)
 
Delaware 0-12933 94-2634797
(State or Other Jurisdiction
of Incorporation)		 (Commission
File Number)		 (IRS Employer
Identification Number)
4650 Cushing Parkway
Fremont, California 94538
(Address of principal executive offices including zip code)
(510) 572-0200
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered
Common Stock, Par Value $0.001 Per ShareLRCXThe Nasdaq Stock Market
(Nasdaq Global Select Market)
Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company      ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.                      ☐

Table of Contents
Table of Contents
 
Item 2.02.  Results of Operations and Financial Condition 
Item 9.01.  Financial Statements and Exhibits 
SIGNATURES 
EX-99.1

Table of Contents
 Item 2.02.Results of Operations and Financial Condition
On October 20, 2021, Lam Research Corporation (the “Company”) issued a press release announcing its financial results for the fiscal quarter ended September 26, 2021, the text of which is attached hereto as Exhibit 99.1.
The information in this item of this Current Report on Form 8-K, including Exhibit 99.1, is furnished pursuant to Item 2.02 and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities under that Section. Furthermore, the information in this item of this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended, or the Exchange Act.
 Item 9.01.Financial Statements and Exhibits
(d) Exhibits
99.1
104Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document

Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date:October 20, 2021
LAM RESEARCH CORPORATION
(Registrant)
 /s/ Douglas R. Bettinger
 Douglas R. Bettinger
 Executive Vice President, Chief Financial Officer
 (Principal Financial Officer and Principal Accounting Officer)
 



Exhibit 99.1
FOR IMMEDIATE RELEASE        
Lam Research Corporation Reports Financial Results for the Quarter Ended September 26, 2021
FREMONT, Calif., October 20, 2021 - Lam Research Corporation (the "Company," "Lam," "Lam Research") today announced financial results for the quarter ended September 26, 2021 (the “September 2021 quarter”).
Highlights for the September 2021 quarter were as follows:
•Revenue of $4.30 billion.
•U.S. GAAP gross margin of 45.9%, U.S. GAAP operating income as a percentage of revenue of 31.9%, and U.S. GAAP diluted EPS of $8.27.
•Non-GAAP gross margin of 46.0%, non-GAAP operating income as a percentage of revenue of 32.4%, and non-GAAP diluted EPS of $8.36.
Key Financial Data for the Quarters Ended
September 26, 2021 and June 27, 2021
(in thousands, except per-share data, percentages, and basis points) 
U.S. GAAP
   September 2021June 2021Change Q/Q
Revenue  $4,304,465 $4,145,179 + 4%
Gross margin as percentage of revenue  45.9 %46.2 %- 30 bps
Operating income as percentage of revenue  31.9 %31.7 %+ 20 bps
Diluted EPS  $8.27 $7.98 + 4%
Non-GAAP
   September 2021June 2021Change Q/Q
Revenue  $4,304,465 $4,145,179 + 4%
Gross margin as percentage of revenue  46.0 % 46.5 %- 50 bps
Operating income as percentage of revenue  32.4 % 32.6 %- 20 bps
Diluted EPS  $8.36  $8.09 + 3%

U.S. GAAP Financial Results
For the September 2021 quarter, revenue was $4,304 million, gross margin was $1,977 million, or 45.9% of revenue, operating expenses were $605 million, operating income was 31.9% of revenue, and net income was $1,180 million, or $8.27 per diluted share on a U.S. GAAP basis. This compares to revenue of $4,145 million, gross margin of $1,915 million, or 46.2% of revenue, operating expenses of $599 million, operating income of 31.7% of revenue, and net income of $1,145 million, or $7.98 per diluted share, for the quarter ended June 27, 2021 (the “June 2021 quarter”).
Non-GAAP Financial Results
For the September 2021 quarter, non-GAAP gross margin was $1,980 million, or 46.0% of revenue, non-GAAP operating expenses were $586 million, non-GAAP operating income was 32.4% of revenue, and non-GAAP net income was $1,192 million, or $8.36 per diluted share. This compares to non-GAAP gross margin of $1,926 million, or 46.5% of revenue, non-GAAP operating expenses of $574 million, non-GAAP operating income of 32.6% of revenue, and non-GAAP net income of $1,161 million, or $8.09 per diluted share, for the June 2021 quarter.
“Driven by strong demand and solid execution, Lam delivered its sixth consecutive quarter of record revenue and earnings per share,” said Tim Archer, Lam Research’s President and Chief Executive Officer. “In a robust wafer fabrication equipment environment, Lam is delivering the innovation needed for the success of our customers' semiconductor manufacturing roadmaps.”





Balance Sheet and Cash Flow Results
Cash and cash equivalents, short-term investments, and restricted cash and investments balances decreased to $4.9 billion at the end of the September 2021 quarter compared to $6.0 billion at the end of the June 2021 quarter. This decrease was primarily the result of $1.2 billion of share repurchases, including net share settlement of employee stock-based compensation; $185.4 million of dividends paid to stockholders; and $136.4 million of capital expenditures, partially offset by $457.5 million of cash generated from operating activities.
Revenue
The geographic distribution of revenue during the September 2021 quarter is shown in the following table:
RegionRevenue
China37%
Korea21%
Taiwan15%
Japan11%
Southeast Asia8%
United States6%
Europe2%
The following table presents revenue disaggregated between system and customer support-related revenue:
Three Months Ended
September 26,
2021		June 27,
2021		September 27,
2020
(In thousands)
System revenue$2,924,883 $2,763,877 $2,148,241 
Customer support-related revenue and other1,379,582 1,381,302 1,028,839 
$4,304,465 $4,145,179 $3,177,080 
System revenue includes sales of new leading-edge equipment in deposition, etch and clean markets.
Customer support-related revenue includes sales of customer service, spares, upgrades, and non-leading-edge equipment from our Reliant® product line.
Outlook

For the quarter ended December 26, 2021, Lam is providing the following guidance:

U.S. GAAPReconciling ItemsNon-GAAP
Revenue$4.4 Billion+/-$250 Million—$4.4 Billion+/-$250 Million
Gross margin as a percentage of revenue46.0%+/-1%$1 Million46.0%+/-1%
Operating income as a percentage of revenue31.7%+/-1%$13 Million32.0%+/-1%
Net income per diluted share$8.37+/-$0.50$12 Million$8.45+/-$0.50
Diluted share count142 Million—142 Million
The information provided above is only an estimate of what the Company believes is realizable as of the date of this release and does not incorporate the potential impact of any business combinations, asset acquisitions, divestitures, restructuring, balance sheet valuation adjustments, financing arrangements, gains or losses on equity investments, other investments, or other significant arrangements that may be completed or recognized after the date of this release. U.S. GAAP to non-GAAP reconciling items provided include only those items that are known and can be estimated as of the date of this release. Actual results will vary from this model and the variations may be material. Reconciling items included above are as follows:

•Gross margin as a percentage of revenue - amortization related to intangible assets acquired through business combinations, $1 million.



•Operating income as a percentage of revenue - amortization related to intangible assets acquired through business combinations, $13 million.

•Net income per diluted share - amortization related to intangible assets acquired though business combinations, $13 million; amortization of note discounts, $1 million; and associated tax benefit for non-GAAP items ($2 million); totaling $12 million.
Use of Non-GAAP Financial Results
In addition to U.S. GAAP results, this press release also contains non-GAAP financial results. The Company’s non-GAAP results for both the September 2021 and June 2021 quarters exclude amortization related to intangible assets acquired through business combinations, the effects of elective deferred compensation-related assets and liabilities, amortization of note discounts, and the income tax benefit of non-GAAP items. Additionally, the June 2021 quarter non-GAAP results exclude product rationalization charges.
Management uses non-GAAP gross margin, operating expense, operating income, operating income as a percentage of revenue, net income, and net income per diluted share to evaluate the Company’s operating and financial results. The Company believes the presentation of non-GAAP results is useful to investors for analyzing business trends and comparing performance to prior periods, along with enhancing investors’ ability to view the Company’s results from management’s perspective. Tables presenting reconciliations of non-GAAP results to U.S. GAAP results are included at the end of this press release and on the Company’s website at http://investor.lamresearch.com.
Caution Regarding Forward-Looking Statements
Statements made in this press release that are not of historical fact are forward-looking statements and are subject to the safe harbor provisions created by the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relate to, but are not limited to: our outlook and guidance for future financial results, including revenue, gross margins, operating income and net income; demand for wafer fabrication equipment; our operational execution; and our ability to deliver innovative products and services to our customers. Some factors that may affect these forward-looking statements include: supply chain disruptions or manufacturing capacity constraints may limit our ability to manufacture and sell our products; trade regulations, export controls, trade disputes, and other geopolitical tensions may inhibit our ability to sell our products; business, political and/or regulatory conditions in the consumer electronics industry, the semiconductor industry and the overall economy may deteriorate or change; the actions of our customers and competitors may be inconsistent with our expectations; the severity, magnitude and duration of the COVID–19 pandemic (and the related governmental, public health, business and community responses to it), and their impacts on our business, results of operations and financial condition, are evolving and are highly uncertain and unpredictable; and widespread outbreaks of illness may impact our operations and revenue in affected areas; as well as the other risks and uncertainties that are described in the documents filed or furnished by us with the Securities and Exchange Commission, including specifically the Risk Factors described in our annual report on Form 10–K for the fiscal year ended June 27, 2021. These uncertainties and changes could materially affect the forward-looking statements and cause actual results to vary from expectations in a material way. The Company undertakes no obligation to update the information or statements made in this release.

Lam Research Corporation is a global supplier of innovative wafer fabrication equipment and services to the semiconductor industry. Lam's equipment and services allow customers to build smaller and better performing devices. In fact, today, nearly every advanced chip is built with Lam technology. We combine superior systems engineering, technology leadership, and a strong values-based culture, with an unwavering commitment to our customers. Lam Research (Nasdaq: LRCX) is a FORTUNE 500® company headquartered in Fremont, Calif., with operations around the globe. Learn more at www.lamresearch.com. (LRCX-F)
Consolidated Financial Tables Follow.
 ###




 
LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data and percentages)
(unaudited) 
 Three Months Ended
 September 26,
2021		June 27,
2021		September 27,
2020
Revenue$4,304,465 $4,145,179 $3,177,080 
Cost of goods sold2,327,711 2,229,978 1,670,901 
Gross margin1,976,754 1,915,201 1,506,179 
Gross margin as a percent of revenue45.9 %46.2 %47.4 %
Research and development382,327 381,749 355,367 
Selling, general and administrative222,194 217,525 189,748 
Total operating expenses604,521 599,274 545,115 
Operating income1,372,233 1,315,927 961,064 
Operating income as a percent of revenue31.9 %31.7 %30.2 %
Other expense, net(28,857)(7,166)(38,792)
Income before income taxes1,343,376 1,308,761 922,272 
Income tax expense(163,632)(164,104)(98,821)
Net income$1,179,744 $1,144,657 $823,451 
Net income per share:
Basic$8.32 $8.02 $5.67 
Diluted$8.27 $7.98 $5.59 
Number of shares used in per share calculations:
Basic141,743 142,662 145,267 
Diluted142,612 143,514 147,248 
Cash dividend declared per common share$1.50 $1.30 $1.30 
 














 LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands)
 
September 26,
2021		June 27,
2021		September 27,
2020
(unaudited)(1)(unaudited)
ASSETS
Cash and cash equivalents$4,042,151 $4,418,263 $4,129,067 
Investments569,472 1,310,872 2,528,841 
Accounts receivable, net3,397,180 3,026,430 2,317,922 
Inventories2,872,141 2,689,294 2,138,050 
Prepaid expenses and other current assets263,738 207,528 161,003 
Total current assets11,144,682 11,652,387 11,274,883 
Property and equipment, net1,372,533 1,303,479 1,133,529 
Restricted cash and investments251,448 252,487 253,458 
Goodwill and intangible assets1,614,959 1,622,499 1,646,343 
Other assets1,181,930 1,061,300 748,795 
Total assets$15,565,552 $15,892,152 $15,057,008 
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current portion of long-term debt and finance lease obligations$6,368 $11,349 $834,138 
Other current liabilities3,402,852 3,516,518 2,572,730 
Total current liabilities3,409,220 3,527,867 3,406,868 
Long-term debt and finance lease obligations4,988,964 4,990,333 4,993,495 
Income taxes payable881,325 948,037 879,870 
Other long-term liabilities466,000 398,727 351,283 
Total liabilities9,745,509 9,864,964 9,631,516 
Temporary equity, convertible notes— — 6,307 
Stockholders’ equity (2)5,820,043 6,027,188 5,419,185 
Total liabilities and stockholders’ equity$15,565,552 $15,892,152 $15,057,008 
 
(1)Derived from audited financial statements.
(2)
Common shares issued and outstanding were 140,811 as of September 26, 2021, 142,501 as of June 27, 2021, and 144,593 as of September 27, 2020.
 




 
LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands, unaudited)
 Three Months Ended
 September 26,
2021		June 27,
2021		September 27,
2020
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income$1,179,744 $1,144,657 $823,451 
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization79,874 78,397 72,912 
Deferred income taxes(13,023)(146,029)(1,850)
Equity-based compensation expense58,099 56,321 55,988 
Other, net(8,690)(27,786)4,339 
Changes in operating assets and liabilities(838,480)330,375 (312,329)
Net cash provided by operating activities457,524 1,435,935 642,511 
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures and intangible assets(136,427)(104,622)(62,806)
Net sale (purchase) of available-for-sale securities738,043 799,965 (737,074)
Other, net(4,923)(6,282)(1,786)
Net cash provided by (used for) investing activities596,693 689,061 (801,666)
CASH FLOWS FROM FINANCING ACTIVITIES:
Principal payments on debt(6,338)(822,046)(19,173)
Treasury stock purchases(1,236,753)(431,255)(448,581)
Dividends paid(185,431)(185,385)(167,129)
Reissuance of treasury stock related to employee stock purchase plan— 56,330 — 
Proceeds from issuance of common stock742 851 5,538 
Other, net188 (269)(2,140)
Net cash used for financing activities(1,427,592)(1,381,774)(631,485)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash(3,776)702 4,082 
Net (decrease) increase in cash, cash equivalents, and restricted cash(377,151)743,924 (786,558)
Cash, cash equivalents, and restricted cash at beginning of period4,670,750 3,926,826 5,169,083 
Cash, cash equivalents, and restricted cash at end of period$4,293,599 $4,670,750 $4,382,525 



 
Non-GAAP Financial Summary
(in thousands, except percentages and per share data)
(unaudited)
Three Months Ended
September 26,
2021		June 27,
2021
Revenue$4,304,465 $4,145,179 
Gross margin$1,979,742 $1,926,323 
Gross margin as percentage of revenue46.0 %46.5 %
Operating expenses$586,477 $573,707 
Operating income$1,393,265 $1,352,616 
Operating income as a percentage of revenue32.4 %32.6 %
Net income$1,191,561 $1,161,211 
Net income per diluted share$8.36 $8.09 
Shares used in per share calculation - diluted142,612 143,514 
Reconciliation of U.S. GAAP Net Income to Non-GAAP Net Income
(in thousands, except per share data)
(unaudited) 
Three Months Ended
September 26,
2021		June 27,
2021
U.S. GAAP net income$1,179,744 $1,144,657 
Pre-tax non-GAAP items:
Amortization related to intangible assets acquired through certain business combinations - cost of goods sold1,092 1,092 
Elective deferred compensation ("EDC") related liability valuation increase - cost of goods sold1,896 4,256 
Product rationalization - cost of goods sold— 5,774 
EDC related liability valuation increase - research and development3,412 7,661 
Product rationalization - research and development— 426 
Amortization related to intangible assets acquired through certain business combinations - selling, general and administrative12,357 12,357 
EDC related liability valuation increase - selling, general and administrative2,275 5,123 
Amortization of note discounts - other expense, net683 923 
Gain on EDC related asset - other expense, net(7,437)(17,184)
Net income tax benefit on non-GAAP items(2,461)(3,874)
Non-GAAP net income$1,191,561 $1,161,211 
Non-GAAP net income per diluted share$8.36 $8.09 
U.S. GAAP net income per diluted share$8.27 $7.98 
U.S. GAAP and non-GAAP number of shares used for per diluted share calculation142,612 143,514 



 
Reconciliation of U.S. GAAP Gross Margin, Operating Expenses and Operating Income to Non-GAAP Gross Margin, Operating Expenses and Operating Income
(in thousands, except percentages)
(unaudited) 
Three Months Ended
September 26,
2021		June 27,
2021
U.S. GAAP gross margin$1,976,754 $1,915,201 
Pre-tax non-GAAP items:
Amortization related to intangible assets acquired through certain business combinations1,092 1,092 
EDC related liability valuation increase1,896 4,256 
Product rationalization— 5,774 
Non-GAAP gross margin$1,979,742 $1,926,323 
U.S. GAAP gross margin as a percentage of revenue45.9 %46.2 %
Non-GAAP gross margin as a percentage of revenue46.0 %46.5 %
U.S. GAAP operating expenses$604,521 $599,274 
Pre-tax non-GAAP items:
Amortization related to intangible assets acquired through certain business combinations(12,357)(12,357)
EDC related liability valuation increase(5,687)(12,784)
Product rationalization— (426)
Non-GAAP operating expenses$586,477 $573,707 
U.S. GAAP operating income$1,372,233 $1,315,927 
Non-GAAP operating income$1,393,265 $1,352,616 
U.S. GAAP operating income as percent of revenue31.9 %31.7 %
Non-GAAP operating income as a percent of revenue32.4 %32.6 %
 
Lam Research Corporation Contacts:
Tina Correia, Investor Relations, phone: 510-572-1615, e-mail: [email protected]